Startup | December 30, 2021
VivaLyf Innovations to launch EzLyf, India's first non-invasive glucometer
The glucometer connects to one’s smartphone and provides actionable diagnostic information
The glucometer connects to one’s smartphone and provides actionable diagnostic information
Flattish volume growth and subdued new launches were key factors for last month
_256_384.jpg)
Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.
In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes, as per WHO
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Contribution from the top five therapies stood at 58% of IPM in October 2021. These therapies are cardiac, anti-infectives, gastro-intestinal, anti-diabetic and vitamins
Diabetes has the highest prevalence and comorbidities among all NCD’s in India and it is mostly found among people in the south and east India
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
The start-up has announced the scheme to mark World Diabetes Day
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
Subscribe To Our Newsletter & Stay Updated
